DOSE-DEPENDENT DECREASE IN HEPARIN ELIMINATION

被引:10
作者
BJORNSSON, TD [1 ]
机构
[1] DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710
关键词
D O I
10.1002/jps.2600711031
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:1186 / 1188
页数:3
相关论文
共 16 条
[1]   INTERSUBJECT VARIABILITY IN THE ANTICOAGULANT RESPONSE TO HEPARIN INVITRO [J].
BJORNSSON, TD ;
WOLFRAM, KM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 21 (06) :491-497
[2]  
BJORNSSON TD, 1979, J PHARMACOL EXP THER, V210, P243
[3]   HEPARIN KINETICS DETERMINED BY 3 ASSAY-METHODS [J].
BJORNSSON, TD ;
WOLFRAM, KM ;
KITCHELL, BB .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (01) :104-113
[4]  
BJORNSSON TD, 1979, J PHARMACOL EXP THER, V210, P237
[5]  
BLOMBACK B, 1959, Acta Chir Scand Suppl, VSuppl 245, P259
[6]  
Choay J, 1981, Ann N Y Acad Sci, V370, P644, DOI 10.1111/j.1749-6632.1981.tb29770.x
[7]   HEPARIN KINETICS - VARIABLES RELATED TO DISPOSITION AND DOSAGE [J].
CIPOLLE, RJ ;
SEIFERT, RD ;
NEILAN, BA ;
ZASKE, DE ;
HAUS, E .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (03) :387-393
[8]  
ESTES JW, 1969, CLIN PHARMACOL THER, V10, P329
[9]   HEPARIN KINETICS IN VENOUS THROMBOSIS AND PULMONARY-EMBOLISM [J].
HIRSH, J ;
VANAKEN, WG ;
GALLUS, AS ;
DOLLERY, CT ;
CADE, JF ;
YUNG, WL .
CIRCULATION, 1976, 53 (04) :691-695
[10]  
HOOK M, 1981, CHEM BIOL HEPARIN, P271